Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2)

Abstract

Background: Penicillin “allergy” labels are prevalent but frequently misdiagnosed. Mislabelled allergies are associated with adverse outcomes and increased antimicrobial resistance. With an urgent need to delabel the overwhelming number of mislabeled allergies, nonallergist evaluations have been advocated for low-risk individuals. Despite growing interest in non–allergist-led initiatives, evidence on their effectiveness, safety, and impact by direct comparisons is lacking. Objective: To assess the comparative outcomes of penicillin allergy evaluations conducted by allergists versus nonallergists. Methods: A prospective, multicenter, pragmatic study was conducted at 4 tertiary hospitals (1 allergist- vs 3 non–allergist-led) for low-risk penicillin allergy patients in Hong Kong—the Hong Kong Drug Allergy Delabelling Initiative 2 (HK-DADI2). Results: Among 228 low-risk patients who underwent testing (32.9% by allergists, 67.1% by nonallergists), only 14 (6.1%) had positive penicillin allergy testing results. Delabeling rates (94.1% vs 93.3%; P =.777), positive skin test results (2.6% vs 2.7%; P >.99), and drug provocation test results (3.3% vs 2.7%; P = 1.000) were similar between allergists and nonallergists. There were no systemic reactions in either cohort. All patients had significant improvements in health-related quality of life (Drug Hypersensitivity Quality of Life Questionnaire scores −5.00 vs −8.33; P =.072). Nonallergist evaluations had shorter waiting times (0.57 vs 15.7 months; P